ClinicalTrials.gg
Enrolling by invitationNCT05191121Updated Mar 30, 2026

Improving Upper Extremity Function and Trunk Stability After Cervical Spinal Cord Injury (SCI)

An interventional study of FTP Alone and FTP+Con-FES in Cervical Spinal Cord Injury, sponsored by Craig Hospital. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-30.

Sponsored by Craig Hospital · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
99
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Spinal Cord Injuries by Craig Hospital — 6 open to participants now, 7 under way, none of them phase 3. Spinal Cord Injuries · Craig Hospital.

Planned enrollment
4th of 17
99 · median 37
Started
2022
with 1 other
No phase
14 of 21
3 open now
Registered
14th of 21
by date

Among the 21 studies in Spinal Cord Injuries by Craig Hospital, this one is the 4th largest by planned enrollment of the 17 interventional ones that give a count, is one of 2 that started in 2022, is one of 14 with no phase, and was the 14th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

6 of the 21 studies in Spinal Cord Injuries by Craig Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Spinal Cord Injuries by Craig Hospital, or all of them as a file.
02

Study summary

Ninety-nine individuals meeting the study's inclusion/exclusion criteria will be enrolled in this study. The objective of this study is to evaluate three different therapeutic approaches to synergistically retrain functional movement patterns of the upper extremities in combination with trunk stabilization to promote neurologic and functional recovery after SCI. Each subject will complete 40 sessions of intervention. Subjects will also complete a Baseline Evaluation (week 0), Re-Evaluation (week 4), Post Treatment Evaluation (week 8), and a Follow-Up Evaluation (week 12).

03

Conditions studied

  • Cervical Spinal Cord Injury
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • History of traumatic SCI
  • Less than 5months post SCI
  • SCI injury level C1-C8
  • SCI categorized as AIS B-D
  • Currently receiving inpatient rehabilitation at Craig Hospital
  • Passive range of motion (ROM) within functional limits at wrists, shoulders, and elbows
  • Demonstrate motor response to electrical stimulation in majority of UE muscle groups below level of injury (tested during screening)
  • No complicating physical or cognitive conditions (as determined by their physician) that would preclude safe use of electrical stimulation
  • Able to complete study as an outpatient if discharged from inpatient rehabilitation before completing 40 sessions of training

Exclusion criteria

Exclusion Criteria:

  • Unstable chronic cardiac or respiratory complaints
  • Current or history of UE contracture or skin pressure injuries that might interfere with intervention
  • Received Botox injections within the last 3 months
  • Pregnant
  • Implanted devices including: pacemaker, spinal cord stimulator, ventriculoperitoneal shunt, deep brain stimulator, or intra-thecal pump.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
99 participants (estimated)

Study arms

  • Active comparator
    FTP Alone

    Functional Task Practice Alone - Participants allocated to this group will complete 40 minutes of training focused on improving functional tasks followed by 10 minutes of functional training/carryover in a relevant environment without functional electrical stimulation (FES).

    Behavioral: FTP Alone

  • Active comparator
    FTP+Con-FES

    Functional Task Practice + Conventional Functional Electrical Stimulation - Participants allocated to this group will complete 40 minutes of training focused on improving functional tasks supplemented with conventional parameter (200µs; 40Hz) functional electrical stimulation (FES). followed by 10 minutes of functional training/carryover in a relevant environment.

    Behavioral: FTP+Con-FES

  • Active comparator
    FTP+WPHF-FES

    Functional Task Practice + Wide Pulse, High Frequency Functional Electrical Stimulation - Participants allocated to this group will complete 40 minutes of training focused on improving functional tasks supplemented with wide pulse, high frequency (1000µs; 100 Hz) functional electrical stimulation (FES) followed by 10 minutes of functional training/carryover in a relevant environment.

    Behavioral: FTP+WPHF-FES

Interventions

  • BehavioralFTP Alone

    Participants will be challenged with training speed, weight, limited therapist support, and context variation (e.g., fine motor activities will vary using objects such as cards, dice, coins).

  • BehavioralFTP+Con-FES

    Participants will be challenged with training speed, weight, limited therapist support, and context variation (e.g., fine motor activities will vary using objects such as cards, dice, coins). Muscle groups will be stimulated at the same time they would be activated naturally in a pre-injury movement pattern utilizing conventional parameter FES.

  • BehavioralFTP+WPHF-FES

    Participants will be challenged with training speed, weight, limited therapist support, and context variation (e.g., fine motor activities will vary using objects such as cards, dice, coins). Muscle groups will be stimulated at the same time they would be activated naturally in a pre-injury movement pattern utilizing wide pulse, high frequency parameter FES.

06

What researchers measure

Primary outcomes

  1. Capabilities of Upper Extremity Test (CUE-T)

    32 item test, each item scored on a 0-4 point scale with total scores ranging from 0-128.

    Time frame: Week 0 to Week 12

Secondary outcomes

  1. Graded Refined Assessment of Strength, Sensibility, and Prehension (GRASSP)

    This multimodal test measures sensorimotor and prehension function in three domains important in describing arm and hand function

    Time frame: Week 0, Week 8, and Week 12

  2. International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Sensory Level

    The ISNCSCI involves a detailed examination to determine the sensory level for the right and left sides. The sensory level is the most caudal, intact dermatome. Scores range from 0-2. The higher the score the more intact the dermatome is.

    Time frame: Week 0, Week 8, and Week 12

  3. International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Motor Level

    The ISNCSCI involves a detailed examination to determine motor levels for the right and left sides. The motor level is defined as the lowest key muscle function that has a grade of at least a 3, providing key muscle functions represented by segments above that level are judged to be intact. Scores range from 0-5. The higher the score the more intact the muscle is.

    Time frame: Week 0, Week 8, and Week 12

  4. International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Neurological Level of Injury

    The ISNCSCI involves a detailed examination to determine the neurological level of injury. The neurological level of injury refers to the most caudal segment of the cord with intact sensation and antigravity muscle function strength, provided that there is normal sensory and motor function rostrally respectively. The neurological level of injury is the most cephalad of the sensory and motor levels.

    Time frame: Week 0, Week 8, and Week 12

  5. International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Sacral Sparing

    The ISNCSCI involves a detailed examination to determine whether a spinal cord injury is complete or incomplete. If an injury is considered complete there is an absence of voluntary anal contraction, absent sensory scores of S4-5, and absence of deep anal pressure.

    Time frame: Week 0, Week 8, and Week 12

  6. International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Impairment Grade

    The ISNCSCI involves a detailed examination to determine a spinal cord injury's grade according to the American Spinal Injury Association. Score ranges from A-E. ASIA classification A means spinal injury is considered complete with no sensory or motor function preserved in sacral segments. On the opposite end of the scale an ASIA classification E means 'normal'.

    Time frame: Week 0, Week 8, and Week 12

  7. Pinch Force

    Pinch force will be measured by the Commander Echo Console with the JTech Pinch Dynamometer to quantify finger strength.

    Time frame: Week 0, Week 8, and Week 12

  8. Grasp Force

    Grasp force will be measured by the Commander Echo Console with the JTech Hand Dynamometer to quantify grasp strength.

    Time frame: Week 0, Week 8, and Week 12

  9. Modified Functional Reach (MFR)

    The MFR will be used to measure dynamic trunk stability

    Time frame: Week 0, Week 8, and Week 12

  10. Global Rating of Change (GRC)

    The Global Rating of Change scale assesses perceived change from an intervention. 9 point Likert scale. Higher positive score reflects great improvement

    Time frame: Week 0, Week 8, and Week 12

  11. NeuroRecovery Scale (NRS)

    The full NRS comprises of 16items. For the purpose of this upper extremity interventional study, only six items will be used that represent a variety of functional upper extremity movement patterns required for ADL management. These scores will be used to guide treatment across all 3 groups. Scores range from 1A-4C. Higher scores reflect greater recovery of spinal cord injury.

    Time frame: Week 0 and Week 4

  12. Demographic Information

    Demographic information will include: age, sex, race/ethnic background, pre-injury education, employment status, marital status, and living situation.

    Time frame: Week 0

  13. Injury Information

    Injury information will include: date of injury, cause of injury, baseline AIS classification, and injury level.

    Time frame: Week 0

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2022 (actual). Primary completion is estimated for Feb 2027, 60 months after the start.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 60 months is above that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 28, 2021
First posted
Jan 13, 2022
StartActual
Feb 23, 2022
Primary completionEst.
Feb 2027
CompletionEst.
Jun 2027
Last update
Mar 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05191121
Lead sponsor
Craig Hospital
Collaborators
National Institute on Disability, Independent Living, and Rehabilitation Research
Responsible party
Candace Tefertiller (Executive Director Research and Evaluation, Craig Hospital) — Principal investigator
First posted
Jan 13, 2022
Start date
Feb 23, 2022
Primary completion
Feb 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Mar 30, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion